Patents by Inventor Georgios Tzortzis

Georgios Tzortzis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220143054
    Abstract: A galactooligosaccharide composition comprising a mixture of disaccharides, trisaccharides, a tetrasaccharide and a pentasaccharide for use in preventing or treating cognitive dysfunction and/or emotional disturbances in neuropsychiatric illnesses or ageing.
    Type: Application
    Filed: January 24, 2022
    Publication date: May 12, 2022
    Inventor: Georgios TZORTZIS
  • Patent number: 11241449
    Abstract: A galactooligosaccharide composition comprising a mixture of disaccharides, trisaccharides, a tetrasaccharide and a pentasaccharide for use in preventing or treating cognitive dysfunction and/or emotional disturbances in neuropsychiatric illnesses or ageing.
    Type: Grant
    Filed: March 17, 2014
    Date of Patent: February 8, 2022
    Assignee: CLASADO RESEARCH SERVICES LIMITED
    Inventor: Georgios Tzortzis
  • Publication number: 20220016149
    Abstract: The present invention provides a method for the prevention of the incidence of and/or a reduction in the duration of acute diarrhoea, particularly in travellers, said method comprising orally administering an oligosaccharide composition, in particular a non-digestible oligosaccharide, to a mammal.
    Type: Application
    Filed: July 19, 2021
    Publication date: January 20, 2022
    Inventors: Georgios TZORTZIS, Glenn R. GIBSON
  • Publication number: 20210330688
    Abstract: The present invention relates to the use of a galactooligosaccharide composition for preventing or reducing the risk of developing metabolic syndrome.
    Type: Application
    Filed: July 2, 2021
    Publication date: October 28, 2021
    Inventors: Georgios TZORTZIS, Jelena VULEVIC
  • Patent number: 11065268
    Abstract: The present invention provides a method for the prevention of the incidence of and/or a reduction in the duration of acute diarrhoea, particularly in travelers, said method comprising orally administering an oligosaccharide composition, in particular a non-digestible oligosaccharide, to a mammal.
    Type: Grant
    Filed: May 27, 2009
    Date of Patent: July 20, 2021
    Assignee: CLASADO RESEARCH SERVICES LIMITED
    Inventors: Georgios Tzortzis, Glenn R. Gibson
  • Patent number: 11052097
    Abstract: The present invention relates to the use of a galactooligosaccharide composition for preventing or reducing the risk of developing metabolic syndrome.
    Type: Grant
    Filed: June 20, 2012
    Date of Patent: July 6, 2021
    Inventors: Georgios Tzortzis, Jelena Vulevic
  • Publication number: 20160045524
    Abstract: A galactooligosaccharide composition comprising a mixture of disaccharides, trisaccharides, a tetrasaccharide and a pentasaccharide for use in preventing or treating cognitive dysfunction and/or emotional disturbances in neuropsychiatric illnesses or ageing.
    Type: Application
    Filed: March 17, 2014
    Publication date: February 18, 2016
    Inventor: Georgios TZORTZIS
  • Publication number: 20140142061
    Abstract: The present invention relates to the use of a galactooligosaccharide composition for preventing or reducing the risk of developing metabolic syndrome.
    Type: Application
    Filed: June 20, 2012
    Publication date: May 22, 2014
    Inventors: Georgios Tzortzis, Jelena Vulevic
  • Publication number: 20120157406
    Abstract: The present invention provides a method for the prevention of the incidence of and/or a reduction in the duration of acute diarrhoea, particularly in travellers, said method comprising orally administering an oligosaccharide composition, in particular a non-digestible oligosaccharide, to a mammal.
    Type: Application
    Filed: May 27, 2009
    Publication date: June 21, 2012
    Inventors: Georgios Tzortzis, Glenn R. Gibson
  • Patent number: 8168414
    Abstract: The present invention concerns a new ?-galactosidase with transgalactosylating activity isolated from Bifidobacterium bifidum. The ?-galactosidase is capable of converting lactose to a mixture of galactooligosaccharides which are ?-linked and unexpectedly produces the ?-linked disaccharide galactobiose. The mixture may be incorporated into numerous food products or animal feeds for improving gut health by promoting the growth of bifidobacteria in the gut, and repressing the growth of the pathogenic microflora.
    Type: Grant
    Filed: March 27, 2007
    Date of Patent: May 1, 2012
    Assignee: Clasado Inc.
    Inventors: Georgios Tzortzis, Athanasios K Goulas, Theodoros Goulas
  • Publication number: 20120058972
    Abstract: The present invention relates to the use of a galactooligosaccharide in the prevention or treatment of an inflammatory disorder, in particular an intestinal inflammatory disorder.
    Type: Application
    Filed: April 23, 2010
    Publication date: March 8, 2012
    Inventors: GeorgĂ­os Tzortzis, Jelena Vulevic, Francesco Attanasio
  • Patent number: 8058047
    Abstract: The present invention concerns a new ?-galactosidase with transgalactosylating activity isolated from Bifidobacterium bifidum. The ?-galactosidase is capable of converting mellibiose to ?-galactobiose disaccharides which may be incorporated into numerous food products or animal feeds for improving gut health by promoting the growth of bifidobacteria in the gut, and repressing the growth of the pathogenic microflora.
    Type: Grant
    Filed: December 19, 2006
    Date of Patent: November 15, 2011
    Assignee: Clasado, Inc.
    Inventors: Georgios Tzortzis, Athanasios K Goulas, Theodoros Goulas
  • Patent number: 8030049
    Abstract: The present invention concerns a ?-galactosidase with transgalactosylating activity isolated from Bifidobacterium bifidum. The ?-galactosidase is capable of converting lactose to a mixture of oligosaccharides which are ?-linked and unexpectedly produces the ?-linked disaccharide galactobiose. The mixture may be incorporated into numerous food products or animal feeds for improving gut health by promoting the growth of bifidobacteria in the gut, and repressing the growth of the pathogenic microflora.
    Type: Grant
    Filed: January 23, 2007
    Date of Patent: October 4, 2011
    Assignee: Clasado Inc.
    Inventors: Georgios Tzortzis, Athanasios K Goulas, Theodoros Goulas
  • Publication number: 20110082102
    Abstract: The present invention relates to the use of an oligosaccharide, in particular a non-digestible oligosaccharide, composition in the prevention or treatment of inflammation, in particular intestinal inflammation.
    Type: Application
    Filed: May 26, 2009
    Publication date: April 7, 2011
    Inventors: Georgios Tzortzis, Jelena Vulevic, Francesco Attanasio
  • Patent number: 7883874
    Abstract: Novel strains of Bifidobacterium hifidum capable of producing a novel galactosidase enzyme activity that converts lactose to a novel mixture of galactooligosaccharides. The mixture of oligosaccharidcs may be incorporated into numerous food products or animal feeds for improving gut health by promoting the growth of bifidobacteria in the gut, and repressing the growth of the pathogenic microflora.
    Type: Grant
    Filed: June 30, 2004
    Date of Patent: February 8, 2011
    Assignee: Clasado Inc.
    Inventors: Glenn Gibson, Jacek Witold Slupinski, Georgios Tzortzis, Anthony Graham Wynne
  • Publication number: 20090285933
    Abstract: The present invention concerns a new ?-galactosidase with transgalactosylating activity isolated from Bifidobacterium bifidum. The ?-galactosidase is capable of converting mellibiose to ?-galactobiose disaccharides which may be incorporated into numerous food products or animal feeds for improving gut health by promoting the growth of bifidobacteria in the gut, and repressing the growth of the pathogenic microflora.
    Type: Application
    Filed: December 19, 2006
    Publication date: November 19, 2009
    Inventors: Georgios Tzortzis, Athanasios K. Goulas, Theodoros Goulas
  • Publication number: 20090155860
    Abstract: A process for producing a prebiotic mixture of galactooligosaccharides from lactose using galactosidase producing bacteria, wherein the bacterial cells may be reused in synthesis reactions without loss of yield of the product.
    Type: Application
    Filed: November 2, 2006
    Publication date: June 18, 2009
    Inventors: Athanasios K. Goulas, Georgios Tzortzis
  • Publication number: 20090117080
    Abstract: The present invention concerns a new ?-galactosidase with transgalactosylating activity isolated from Bifidobacterium bifidum. The ?-galactosidase is capable of converting lactose to a mixture of galactooligosaccharides which are ?-linked and unexpectedly produces the ?-linked disaccharide galactobiose. The mixture may be incorporated into numerous food products or animal feeds for improving gut health by promoting the growth of bifidobacteria in the gut, and repressing the growth of the pathogenic microflora.
    Type: Application
    Filed: March 27, 2007
    Publication date: May 7, 2009
    Inventors: Georgios Tzortzis, Athanasios K. Goulas, Theodoros Goulas
  • Publication number: 20090110770
    Abstract: The present invention concerns a ?-galactosidase with transgalactosylating activity isolated from Bifidobacterium bifidum. The ?-galactosidase is capable of converting lactose to a mixture of oligosaccharides which are ?-linked and unexpectedly produces the ?-linked disaccharide galactobiose. The mixture may be incorporated into numerous food products or animal feeds for improving gut health by promoting the growth of bifidobacteria in the gut, and repressing the growth of the pathogenic microflora.
    Type: Application
    Filed: January 23, 2007
    Publication date: April 30, 2009
    Inventors: Georgios Tzortzis, Athanasios K. Goulas, Theodoros Goulas
  • Publication number: 20070274955
    Abstract: Novel strains of Bifidobacterium hifidum capable of producing a novel galactosidase enzyme activity that converts lactose to a novel mixture of galactooligosaccharides. The mixture of oligosaccharidcs may be incorporated into numerous food products or animal feeds for improving gut health by promoting the growth of bifidobacteria in the gut, and repressing the growth of the pathogenic microflora.
    Type: Application
    Filed: June 30, 2004
    Publication date: November 29, 2007
    Inventors: Glenn Gibson, Jacek Slupinski, Georgios Tzortzis, Anthony Wynne